3StocksOnFire — US Stock Trading Community · 451+ trades · 257% returns · 15,000 members · Main Site · Trader's Guide · Articles · Video Analyses
3 Stocks On Fire
3StocksOnFire Community Forum
Home Message Boards Trader's Guide Articles Video Analysis About Us Search Register

BNVI.OB--- LEAD BREAST CANCER CANIDATE

Started by pompano, January 04, 2007, 06:51:13 PM

Previous topic - Next topic

pompano

BUSINESS SUMMARY    

Bionovo, Inc., a development stage company, engages in the discovery and development of drugs in the areas of cancer and women's health primarily in the United States. It develops drugs to treat breast and ovarian cancers, and for menopause. The company's product and drug pipeline includes MF101, a selective estrogen receptor beta agonist, which is designed to alleviate the symptoms of menopause, including hot flashes, night sweats, and bone mineral loss; and BZL101, an apoptosis inducing factor translocator/activator, which is used as an anticancer agent for breast and ovarian cancers, as well as used for the treatment of other solid tumors. In addition, its drug pipeline, which is not entered human clinical trials includes AA102, an apoptosis inducer, which is used as an anticancer agent that attenuates mitochodrial membrane potential to cause a cytochrome c release and caspase activation to induce apoptosis; and VG101, vasodilator and an antimicrobial agent, which is an intra-vaginal gel for the treatment of postmenopausal vaginal dryness. The company has collaboration with the University of California at San Francisco; University of California at Berkeley; University of California at Davis; University of Texas, Southwestern; and University of Colorado Health Sciences College. Bionovo was founded in 2002 and is headquartered in Emeryville, California


Does somebody know something about the recent breast cancer trial???  The chart seems to think so.

http://biz.yahoo.com/prnews/061129/sfw042.html?.v=82

"Due to the strength of our pre-clinical data in breast cancer models, we chose to conduct this study in women with advanced breast cancer rather than a cohort of patients with many different types of tumors," said Dr. Debu Tripathy, MD, Director of the Komen/UT Southwestern Breast Cancer Research Center at the University of Texas Southwestern Medical Center, and Principal Investigator on the trial. "Data from the trial showed that BZL101 demonstrated encouraging clinical activity in this heavily pre-treated population."

CHART               SHE'S GONNA BLOW!!


gmarc66

Nice Pompano....how the heck did we let this one go by ???

pretty

julia

pompano

#2
Not enough volume till today, which came without any news .  I think their is more to come, news on that breast cancer trial must be imminent.  Keep this one one watch Julia.

pompano

Watch for the G-spot breakout above 1.88. ;)

pompano

#4
Got the breakout today with a close at 1.90, so technically it looking good. Any news and this sucker flys.  ;)

gmarc66

I did watch this one today as I put it on my watchlist since u gave us the heads up on it. ;)

Yes...it did hit the g-spot, now we just need clearance and take-off :D

looks good.

glta

julia

pompano

Very Nice!!


pompano

Is it hot in here, or is that me? 8)   BNVI.ob   --------  ON FIRE ----------

pompano

#9
Can you say fire!!!!! 8)     All time highs, should break volume record.  Buy on the pullback!!!!

pompano


pompano

HERES THE CHART.

pompano

#12
Beautiful chart, suggested entry around 2.4

pompano

Movin on up!! ;D